Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A modified drug regimen clears active and dormant trypanosomes in mouse models of Chagas disease

Science Translational Medicine(2020)10.1126/scitranslmed.abb7656Source: DataRank Database

A modified drug regimen clears active and dormant trypanosomes in mouse models of Chagas disease is a research paper published in Science Translational Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 66 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access66 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: greenTopics (7)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Fernando Sánchez-Valdéz ORCID,Ángel M. Padilla ORCID,Brooke E. White ORCID,Wei Wang ORCID,Rick L. Tarleton ORCID

Live enrichment

PubMed:33115952 PMC:PMC7926267

National Institute of Allergy and Infectious Diseases

Grant: AI124692

National Institute of Allergy and Infectious Diseases

Grant: AI142469

NIAID NIH HHS

Grant: R01 AI151148

NIAID NIH HHS

Grant: R21 AI142469

NIAID NIH HHS

Grant: R21 AI108265

NIAID NIH HHS

Grant: R01 AI124692

greenLicense: cc-by-nc-sa

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7926267

publisherhttps://syndication.highwire.org/content/doi/10.1126/scitranslmed.abb7656

publisherhttps://www.science.org/doi/pdf/10.1126/scitranslmed.abb7656

repositoryhttp://hdl.handle.net/11336/141920

MeSH Terms

AnimalsMiceTrypanosoma cruziChagas DiseaseDisease Models, AnimalPharmaceutical PreparationsTrypanocidal Agents

Related Papers (6)

Short-course Benznidazole treatment to reduce Trypanosoma cruzi parasitic load in women of reproductive age (BETTY): a non-inferiority randomized controlled trial study protocol

N/A

1.2DataRank · unranked

Reproductive Health(2020)

co-cited

10.1186/s12978-020-00972-1

Declining antibody levels to Trypanosoma cruzi correlate with polymerase chain reaction positivity and electrocardiographic changes in a retrospective cohort of untreated Brazilian blood donors

PLoS neglected tropical diseases(2020)

co-cited

10.1371/journal.pntd.0008787

New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial

N/A

4.6DataRank · unranked

The Lancet Infectious Diseases(2021)

co-cited

10.1016/s1473-3099(20)30844-6

Strain-specific genome evolution in Trypanosoma cruzi, the agent of Chagas disease

PLoS Pathogens(2021)

co-cited

10.1371/journal.ppat.1009254

High incidence of Trypanosoma cruzi infections in dogs directly detected through longitudinal tracking at 10 multi-dog kennels, Texas, USA

PLoS neglected tropical diseases(2021)

co-cited

10.1371/journal.pntd.0009935

HISAT: a fast spliced aligner with low memory requirements

N/A

1.5DataRank · unranked

Nature Methods(2015)

co-cited

10.1038/nmeth.3317